Heron Therapeutics | HRTX - Stock


Heron Therapeutics reported $54.57M in Stock for its fiscal quarter ending in December of 2022.





Stock Change Date
ALKERMES USD 196.62M 5.63M Dec/2025
Alnylam Pharmaceuticals USD 82.72M 7.34M Dec/2025
Amarin USD 184.7M 13.46M Sep/2025
ANI Pharmaceuticals USD 143.07M 3.41M Dec/2025
Anika Therapeutics USD 18.79M 2.5M Dec/2025
Arrowhead Research USD -173.08M 173.08M Dec/2024
Eisai JPY 236.46B 9.14B Sep/2025
Emergent BioSolutions USD 328.9M 25.2M Dec/2023
Esperion Therapeutics USD 108.54M 5.93M Sep/2025
GlaxoSmithKline GBP 6.12B 46M Sep/2025
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Insmed USD 132.07M 11.1M Dec/2025
Ligand Pharmaceuticals USD 9.13M 2.77M Dec/2025
Merck USD 6.44B 157M Sep/2025
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Neurocrine Biosciences USD 69M 300K Dec/2025
Omeros USD 712K 266K Sep/2021
Pacira USD 152.86M 4.82M Dec/2025
Regeneron Pharmaceuticals USD 3.2B 53.6M Dec/2025
Roche Holding CHF 7.6B 9M Jun/2025
Surmodics USD 15.17M 230K Sep/2024
Ultragenyx Pharmaceutical USD 52.2M 5.7M Sep/2025
Veracyte USD 20.55M 219K Dec/2025
Vertex Pharmaceuticals USD 1.69B 60M Dec/2025